快好知 kuaihz


retinal造句
121. Results In the model group, damage to retinal structure appeared 1 day after reperfusion IRL. 122. Conclusions The primary causes after scleral buckling were new retinal breaks, PVR development and SRF unabsorbed. 123. ObjectiveTo investigate the relationship between disk area and retinal nerve fibril layer(RNFL)thickness in patients with large cup. 124. In this image retinal blood vessels are shown to emerge from the black - coloured optic disc. 125. One month later, the vitreous hemorrhage decreased, and ophthalmoscopy examination revealed a white, elevated, retinal tumor involving the inferior optic disc. 126. Methods Dynamic contrast analysis was made on the changes of retinal blood vessels by using ophthalmoscope. 127. Serum retinal, serum prealbumin, serum retinal binding protein, haematoglobin, height and body mass of children before intervention and after interventional for 3 months in every group. 128. The correlationship between the blood velocities of the ocular artery(OA), central retinal artery (CRA)and the blood viscosity in patients with primary open-angle glaucoma (74 eyes) were analysed. 129. In this image, stained retinal blood vessels are shown to emerge from the black - coloured optic disc. 130. On OCT choroidal folds involved choroid and retinal pigment epithelial layer ( RPEL ). 131. Chemoreduction treatment combined with local treatment may effectively control the retinal tumor, subretinal seeds and vitreous seeds within a short-teen duration. 132. Nitric oxide ( NO ) is a new class of retinal neurotransmitter discovered late years. 133. Three essential elements of glaucomatous optic nerve damages are optic nerve rim loss, retinal nerve fiber layer defects (RNFLD) and optic disc linear hemorrhages. 134. Methods 24 hour urinary ablumin ( Alb ), transferrin ( TRF ), IgG, retinal - bingding protein ( RBP ), N - acetyl - glucosaminidase ( NAG ) , fasting blood glucose, < ... 135. Glaucoma is a neurodegenerative disease characterized by progressive loss of retinal ganglion cells and optic nerve axons, and accompanied by loss of visual field sensitivity. 136. Retinal infusion injury in intervention fibrinolysis by micropuncture of retina! veinRetinal vein occlusion is a common blinded illness. 137. The postoperative complication membrana vitreous anterior opacification and retinal detachment opacification. They were happened among 40 eyes. 138. Conclusion Window defect hyperfluorescence of FFA and choroidal vessel dilatation of ICGA on the artificial ridge were the main characteristics in reattachment of rhegmatogenous retinal detachment. 139. Objective To evaluate the clinic value of non expanded perfluoropropane gas for management of complicated retinal detachment. 140. Objective:To learn the blood flow of the ophthalmic artery and central retinal artery in 50 senile diabetes patients and to provide some reference values. 141. To observe the clinical effect of radial optic neurotomy (RON) for central retinal vein occlusion (CRVO). 142. With the development of the multi-electrode recording technique, concerted activity has been extensively observed in retinal ganglion cells of different species. 143. Conclusion:Results of FFA with retinal degeneration show barrier of choroidal capillary atrophy may be one factor for RPE and neurosensory retina dystrophy. 144. Objective: In order to demonstrate the etiological diagnosis of acute retinal necrosis ( ARN ). 145. CONCLUSION: Argon laser photocoagulation is one of effective methods in treatment of hole without retinal detachment. 146. Objective To discuss surgical management of giant rhegmatogenous retinal detachment with intraocular lens and aphakic eye. 147. Clinically for the treatment central retinal vein occlusion, stroke sequela, internal ophthalmopathy, Hyphema and other diseases. 148. Photoelectric current and lifetime of vision mimetic retinal membrane has also been much improved ... 149. Objective To investigate the changes of the neurosensory retinal thickness in the macula in high myopia eyes by optical coherence tomography (OCT). 150. Objective:To develop a method for treatment of retinal vein occlusion by infusing thrombolytic agents into the retinal vein with micropuncture of the retinal vein.